ID   CFGA_TACTR              Reviewed;         673 AA.
AC   Q27082;
DT   17-JUN-2020, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-MAY-2022, entry version 80.
DE   RecName: Full=Clotting factor G alpha subunit {ECO:0000303|PubMed:8288603};
DE            EC=3.2.1.- {ECO:0000305};
DE   Flags: Precursor;
OS   Tachypleus tridentatus (Japanese horseshoe crab).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Merostomata;
OC   Xiphosura; Limulidae; Tachypleus.
OX   NCBI_TaxID=6853 {ECO:0000312|EMBL:BAA04044.1};
RN   [1] {ECO:0000312|EMBL:BAA04044.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 20-28; 78-103; 108-133;
RP   212-236; 366-373; 424-436; 440-467; 412-427 AND 581-588, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8288603; DOI=10.1016/s0021-9258(17)42267-8;
RA   Seki N., Muta T., Oda T., Iwaki D., Kuma K., Miyata T., Iwanaga S.;
RT   "Horseshoe crab (1,3)-beta-D-glucan-sensitive coagulation factor G. A
RT   serine protease zymogen heterodimer with similarities to beta-glucan-
RT   binding proteins.";
RL   J. Biol. Chem. 269:1370-1374(1994).
RN   [2] {ECO:0000305}
RP   FUNCTION, SUBUNIT, TISSUE SPECIFICITY, BIOTECHNOLOGY, AND PROTEOLYTIC
RP   CLEAVAGE.
RX   PubMed=7822328; DOI=10.1074/jbc.270.2.892;
RA   Muta T., Seki N., Takaki Y., Hashimoto R., Oda T., Iwanaga A., Tokunaga F.,
RA   Iwanaga S.;
RT   "Purified horseshoe crab factor G. Reconstitution and characterization of
RT   the (1-->3)-beta-D-glucan-sensitive serine protease cascade.";
RL   J. Biol. Chem. 270:892-897(1995).
CC   -!- FUNCTION: Component of the heterodimer clotting factor G which may play
CC       a role in defense mechanisms against fungi (Probable). Initiates a
CC       (1->3)-beta-glucan-sensing clotting pathway whereby the alpha subunit
CC       binds to glucans containing (1->3)-beta linkages, which are components
CC       of the fungal cell wall, and the beta subunit catalyzes the activation
CC       of proclotting enzyme (PubMed:7822328). {ECO:0000269|PubMed:7822328,
CC       ECO:0000305|PubMed:7822328}.
CC   -!- SUBUNIT: Clotting factor G is a heterodimer composed of two non-
CC       covalently associated subunits, alpha and beta.
CC       {ECO:0000269|PubMed:7822328}.
CC   -!- TISSUE SPECIFICITY: Expressed in hemocytes (at protein level).
CC       {ECO:0000269|PubMed:7822328, ECO:0000269|PubMed:8288603}.
CC   -!- PTM: In presence of (1->3)-beta-glucan, proteolytically cleaved into a
CC       55kDa and a 17kDa forms. {ECO:0000269|PubMed:7822328}.
CC   -!- BIOTECHNOLOGY: Clotting factor G is a component of the Limulus test
CC       used to detect bacterial endotoxins in fluids.
CC       {ECO:0000305|PubMed:7822328}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 16 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01098}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D16622; BAA04044.1; -; mRNA.
DR   PIR; A49878; A49878.
DR   AlphaFoldDB; Q27082; -.
DR   SMR; Q27082; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; CBM6; Carbohydrate-Binding Module Family 6.
DR   CAZy; GH16; Glycoside Hydrolase Family 16.
DR   MEROPS; X14.001; -.
DR   GO; GO:1905370; C:serine-type endopeptidase complex; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0042381; P:hemolymph coagulation; IDA:UniProtKB.
DR   CDD; cd00161; RICIN; 1.
DR   InterPro; IPR006584; Cellulose-bd_IV.
DR   InterPro; IPR005084; CMB_fam6.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR000757; GH16.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF03422; CBM_6; 2.
DR   Pfam; PF00722; Glyco_hydro_16; 1.
DR   Pfam; PF14200; RicinB_lectin_2; 2.
DR   SMART; SM00606; CBD_IV; 2.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF49785; SSF49785; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   PROSITE; PS51175; CBM6; 2.
DR   PROSITE; PS51762; GH16_2; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Glycoprotein; Glycosidase; Hemolymph clotting;
KW   Hydrolase; Lectin; Repeat; Signal.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000269|PubMed:8288603"
FT   CHAIN           20..673
FT                   /note="Clotting factor G alpha subunit"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5013107839"
FT   DOMAIN          27..257
FT                   /note="GH16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01098"
FT   DOMAIN          266..404
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DOMAIN          411..533
FT                   /note="CBM6 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00523"
FT   DOMAIN          549..671
FT                   /note="CBM6 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00523"
FT   ACT_SITE        137
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01098"
FT   ACT_SITE        142
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01098"
FT   SITE            169..170
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000305|PubMed:8288603"
FT   CARBOHYD        186
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
SQ   SEQUENCE   673 AA;  75952 MW;  B6CD46C3480D2333 CRC64;
     MLVLLCCVVL HVGVARICCS HEPKWQLVWS DEFTNGISSD WEFEMGNGLN GWGNNELQYY
     RRENAQVEGG KLVITAKRED YDGFKYTSAR LKTQFDKSWK YGKIEAKMAI PSFRGVWVMF
     WMSGDNTNYV RWPSSGEIDF IEHRNTNNEK VRGTIHWSTP DGAHAHHNRE SNTNGIDYHI
     YSVEWNSSIV KWFVNGNQYF EVKIQGGVNG KSAFRNKVFV ILNMAIGGNW PGFDVADEAF
     PAKMYIDYVR VYQDASTSSP VGDTSLDGYY FVQNRHSELY LDVTDASNED GAFLQQWSYS
     GNENQQFDFE HLENNVYKIT NKKSGKSLDV YNFGTENGVR IQQWSYGGAR NQQFTVQSVG
     DGYYKIIPRG SGKLVEVADF SKDAGGKIQQ WSDNNQLSGQ WKLIKSKSYS KLIQAESYFD
     SSKVQLEDTS DVGGGKNVKC DNEGAWMAYK DIDFPSSGNY RIEYRVASER AGGKLSLDLN
     AGSIVLGMLD VPSTGGWQKW TTISHTVNVD SGTYNLGIYV QRASWNINWI KITKIPEQSN
     LNQGRRNSKL IQAESYFSYS EVQLEDTLDV GGGKNVKCDK EGAWMAYKDI DFPSSGSYRV
     EYRVASERAG GKLSLDLNAG SIVLGMLDIP STGGLQKWTT ISHIVNVDLG TYNLGIYVQK
     ASWNINWIRI TKV
//
